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Introduction
Age-related macular degeneration (AMD) is the leading cause of  central retinal vision loss worldwide, and it 
has been estimated that 10% of people over the age of  55 already show early signs of  disease. AMD presents 
in 2 forms that are generally referred to as either “dry” or “wet” AMD (1). Choroidal neovascularization 
(CNV), associated with wet AMD, occurs when blood vessels sprout from the underlying choroidal vascu-
lature, disrupting the integrity of  the retina and leading to acute vision loss. CNV occurs in approximately 
1 in 10 AMD patients and can be treated with regular intraocular injection of  antibodies or fusion proteins 
directed against VEGF (2). The end stage of  “dry” AMD is termed geographic atrophy (GA), where the 
retinal pigment epithelium (RPE) progressively degenerates in the region of  the macula and can eventually 
lead to death of  cone photoreceptor cells and eventually central retinal vision loss (3). There is currently no 
therapeutic for GA other than recommended lifestyle changes, such as smoking cessation and dietary modifi-
cation (4). Given the pervasive nature of  AMD in the developed world and the wealth of  research in this area, 
the underlying molecular pathology associated with GA development is still far from clear, with the majority 
of  studies to date focused on understanding aberrant signaling and inflammatory mechanisms in the RPE.
The major early pathological hallmark common to both dry and wet AMD is the accumulation of  
drusen between the RPE and the choroid, with reticular pseudodrusen depositing in the subretinal space 
in some patients with late AMD and GA. Drusen is composed of  extracellular components, including, but 
not limited to, amyloid-β, vitronectin, cholesterols, and almost every complement component (5). These 
components have all previously been identified in several tissues, including blood and photoreceptors, and 
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it is most likely that AMD is primarily a condition that involves aberrant clearance mechanisms. Indeed, 
the source of  extracellular materials in drusen has been characterized; the materials appear to be dominat-
ed by linoleate, implicating diet as the major contributor (6, 7).
Daily, RPE cells phagocytose POS that are shed during renewal of  photoreceptors (8). Although some 
of  the phagocytosed material is recycled to replenish essential components of  the photoreceptors, oth-
er components in the material are exocytosed to the basolateral compartment of  the RPE and are likely 
cleared by the systemic immune system via the choriocapillaris (9). This is a highly regulated process con-
trolled by autophagic and phagocytic processes, and dysfunctional rates of  clearance are likely a significant 
contributing factor to drusen accumulation in some individuals, as evidenced by residual body buildup in 
lysosomes observed in the RPE of  AMD donor eyes (10, 11).
Although drusen deposition and localization differ from individual to individual, it is pertinent to 
consider that there is a considerable degree of  symmetry in drusen patterning in each eye of  a single 
individual (12, 13). This correlates with an equally high degree of  interocular symmetry of  retinal blood 
vessels between right and left eyes. These blood vessels, which form the inner blood-retina barrier (iBRB), 
are critical to maintaining retinal homeostasis (14, 15). Endothelial cells that line these vessels have evolved 
tight junctions, a series of  up to 30 interacting proteins that limit the paracellular space between endothelial 
cells to all but the smallest of  molecules. As well as regulating the exchange of  ions and macromolecules 
between the blood and the delicate neural microenvironment, these highly specialized endothelial cells 
protect the retina by restricting the entry of  potentially damaging blood-borne agents, such as neurotoxic 
chemicals, antibodies, pathogens, immune cells, and anaphylatoxins. They also express a variety of  trans-
porters to control both the selective transport of  nutrients into the retina and the efflux of  metabolites and 
toxins from the retina via the transcellular pathway (16–19).
Here, we provide evidence that one of  the most enriched tight junction components at the iBRB, clau-
din-5 (20), is under the control of  the transcription factor BMAL1 and the circadian clock. In addition, 
regulating its expression can very rapidly lead to an RPE atrophy phenotype in preclinical mouse and 
nonhuman primate models, and human subjects show evidence of  a dynamic iBRB following fundus fluo-
rescein angiography (FFA). Our data suggest that regulating the dynamic expression pattern of  claudin-5 at 
the iBRB could control the burden of  material consumed by the RPE daily. To our knowledge our findings 
represent the first description of  iBRB cycling with pathophysiological implications for the most common 
untreated forms of  central retinal blindness.
Results
Claudin-5 expression at the iBRB is regulated by the circadian clock. Claudin-5 is the most enriched component of  
both the brain and retinal endothelial tight junctions (20). Indeed, its dose-dependent expression is critical, 
with knockout mice dying within hours of  birth (19, 21). In neural tissues (cerebellum, hypothalamus, brain-
stem), we discovered that claudin-5 transcript levels varied depending on the time of  day of  tissue collection 
(P = 0.00051) (Figure 1A). Unusually, this phenomenon was observed in every tissue examined, with clau-
din-5 transcript levels being lower in the evening when compared with the morning in all tissues (Figure 1B). 
Indeed, when we specifically harvested retinas from mice every 4 hours over a 24-hour period, we observed 
a distinct phase of  transcription mirroring all other tissues, where claudin-5 levels significantly decreased 
during a 12-hour period before increasing again (Figure 1C). This change in retinal claudin-5 expression was 
observed in the evening compared with the morning at both the protein and transcript level (Figure 1D, P = 
0.0064; and Figure 1E, P = 0.042). These transcriptional differences in claudin-5 expression were confirmed 
as circadian as opposed to diurnal because dark-adapted (DA) mice showed the same pattern of  expression 
(Figure 1F) as did mice that had their circadian rhythms inverted by altering their light cycle (Figure 1G). 
Although other tight junction components ZO-1 and occludin appeared to cycle depending on the time 
of  the day, these did not appear to be circadian in nature (Supplemental Figure 1; supplemental material 
available online with this article; https://doi.org/10.1172/jci.insight.130273DS1). Levels of  claudin-5 were 
decreased in the microvasculature of  the retina in the evening compared with the morning (Figure 1H), and 
this was accompanied by the increased extravasation of  a tracer molecule (EZ-Link-Biotin, 660-Da MW), 
with enhanced tracer signal observed in mice in the outer plexiform layer (OPL) and inner/outer segment 
regions of  the retina in the evening compared with the morning (Figure 1, I and J, P = 0.0184).
Size-selective regulation of  the iBRB. In mice examined using dynamic contrast-enhanced MRI (DCE-
MRI), enhanced gadolinium (800-Da MW) signal was observed in the retina in the evening when compared 
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with the morning (Figure 2A, P < 0.001), and this was also manifested when fundus fluorescein angiograms 
(FFAs) were conducted, with enhanced sodium fluorescein (376-Da MW) signal observed in the deeper vas-
cular plexus in the evening when compared with the morning (Figure 2B, P < 0.001). This was also observed 
in other strains of  mice, including 129SV and CD1 mice (Supplemental Figure 2). Intriguingly, this circadian 
change in permeability appeared to be size selective because no differences were observed in FFA analysis 
using an FITC-labeled dextran molecule of  4 kDa (FITC-Dextran) (Figure 2C), suggesting claudin-5 cycling 
at the iBRB is regulating the passive diffusion of  molecules below this molecular weight.
Bmal-1 regulates claudin-5 levels in mouse and human retinal endothelial cells. Bmal-1 is a transcription 
factor that is an essential component of  the circadian clock (22). In mice with a targeted disruption of  
Bmal-1 expression in the vascular endothelium (Bmal1fl/fl Tie2-Cre), levels of  claudin-5 protein remained 
unchanged in the retinas of  mice between the morning and evening (Figure 3A), and this effect was 
observed at the transcript level even in mice lacking only a single Bmal1 allele in the retinal endothe-
lium (Figure 3B). The levels and pattern of  expression of  claudin-5 appeared the same in retinas of  
Bmal1fl/fl Tie2-Cre+ mice (Figure 3C), and there was no difference between FFAs performed in these 
mice in the morning and evening (Figure 3, D and E). This phenotype was also observed in mice with 
a single Bmal1 allele remaining, namely Bmal1WT/fl Tie2-Cre (Supplemental Figure 3).
Figure 1. Claudin-5 cycling in the inner retina. (A) Claudin-5 transcript cycling in the mouse cerebellum, hypothalamus, and brainstem. (B) Claudin-5 
cycling in the mouse aorta, lung, heart, white fat, liver, adrenal gland, muscle, and brown fat (*P = 0.00051), from data collated from open-source data 
available on http://cirgrdb.biols.ac.cn/. (C) Claudin-5 transcript cycling in the neural retina over a 24-hour period (**P < 0.01, *P < 0.05, and n = 7–11 
mice). (D) Western blot analysis of claudin-5 expression at 8 am compared with 8 pm. Densitometric analysis (right, **P = 0.0064). (n = 5 mice for each 
time point.) (E) qPCR analysis of claudin-5 transcript at 8 am compared with 8 pm (*P = 0.042, and n = 5 mice for both time points). (F) Transcript levels 
at 8 am compared with 8 pm in mice dark adapted (DA) for 24 hours (*P = 0.0483, n = 5 mice for DA-AM, and n = 4 mice for DA-PM). (G) Levels of clau-
din-5 transcript in mice with inverted circadian rhythm (*P = 0.0235, n = 3 mice for morning, and n = 4 mice for inverted). (H) Claudin-5 (red) levels in the 
retinas of mice at 8 am (left) compared with 8 pm (right). ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer; scale bar: 100 μm. 
High-magnification images of claudin-5 (red) in the retinas of mice at 8 am (left) compared with 8 pm (right); scale bar: 50 μm. (I) EZ-Link-Biotin (red) 
extravasation in the inner and outer segments of the photoreceptors at 8 pm compared with 8 am. Retinal vasculature stained with isolectin IB4 (green); 
scale bar: 50 μm. (J) Significant extravasation of EZ-Link-Biotin in the outer segments, ONL, and OPL (*P = 0.0184). No significant signal observed in the 
INL, inner plexiform layer (IPL), or GCL. Student’s t test, with significance represented by a P value of less than or equal to 0.05. For multiple compari-
sons, ANOVA was used with Bonferroni’s post hoc test and significance represented by a P value of less than or equal to 0.05.
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Cells in vitro do not have an entrained circadian rhythm; however, rhythmicity can be induced by 
serum shocking cells with 50% serum for 2 hours (23). Endothelial cells were exposed to a serum shock, 
and claudin-5 levels were observed to cycle in a manner identical to that observed in mice (Figure 3F). 
RNAi-mediated suppression of  the expression of  BMAL1 in endothelial cells before serum shock, howev-
er, resulted in a transient cessation of  claudin-5 cycling (Figure 3, G and H) that was accompanied by a 
decrease in transendothelial electrical resistance (TEER) and a discontinuous pattern of  expression at the 
plasma membrane of  cells (Figure 3, I and J).
Targeted suppression of  claudin-5 with a high-cholesterol diet induces RPE atrophy. To recapitulate a 
persistent phenotype similar to that observed in WT mice in the evening (i.e., high sodium fluorescein 
signal), we subretinally injected an adeno-associated virus (AAV9) vector expressing claudin-5 shRNA 
under the control of  a doxycycline-inducible promoter. A nontargeting (NT) AAV9 vector expressing 
doxycycline-inducible shRNA targeting the nonmammalian gene luciferase was used as a control. It is 
well established that environmental factors, such as smoking and a high-fat/high-cholesterol diet, are 
major risk factors for AMD; in that regard, mice were fed a high-cholesterol diet (HCD) as described 
previously (24), and doxycycline was supplemented in the drinking water. Within 3 weeks of  constant 
claudin-5 suppression, enhanced sodium fluorescein extravasation was observed in mice fed a normal 
Figure 2. iBRB integrity in the morning compared to the evening in mice. (A) Gadolinium (800-Da MW) extravasation in the retina of mice at 8 pm (right) 
compared with 8 am (left). Dynamic contrast-enhanced MRI (DCE-MRI) is quantified in histogram at right. ***P < 0.001 (n = 5 mice for 8 am, and n = 4 
mice for 8 pm). (B) Fundus fluorescein angiography (FFA) 3, 5, and 10 minutes after sodium fluorescein (MW: 376 Da) injection at 8 am (top) compared 
with 8 pm (bottom), with enhanced signal at 8 pm (***P < 0.001, and n = 12 mice for both time points). (C) FFA analysis of FITC-Dextran-4 (FD4) (MW: 
4000 Da) at 8 am (top) compared with 8 pm (bottom) (n = 8 mice for both time points). ANOVA was used with Bonferroni’s post hoc test and significance 
represented by a P value of less than or equal to 0.05.
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diet (Figure 4A, top). However, in mice with suppressed claudin-5 fed an HCD, enhanced fluorescein 
signal was observed in the deeper vascular plexus with apparent hyperreflectivity of  the underlying 
RPE (Figure 4A, bottom). Analysis of  histological sections of  the retina showed enlarged subretinal 
cells that contained a large amount of  autofluorescent material (Figure 4B). Depigmented RPE cells 
and in some areas a lack of  RPE cells was evident in semithin sections of  retinas from these mice 
(Figure 4C). Analysis of  flat mounts from eyes of  these mice stained for the tight junction component 
ZO-1 showed regions of  atrophic RPE where the underlying choroid was visible (Figure 4D). Because 
claudin-5 is not expressed in the RPE, and the AAV will transduce endothelial cells only within the 
retinal side of  the outer blood-retina barrier, these data are strongly suggestive of  the passive para-
cellular diffusion of  material from the systemic circulation toward the RPE (Figure 4E). To suppress 
claudin-5 in both the retina and the choriocapillaris, we developed a mouse model that would allow 
us to induce suppression of  claudin-5 throughout the whole body (Figure 4, F and G, and ref. 21). A 
similar phenotype was observed in these mice with a targeted “knockin” of  claudin-5 shRNA, with 
enlarged and vesiculated RPE cells observed (Figure 4H) in mice with decreased levels of  claudin-5 fed 
a cholesterol-rich diet. These mice died following chronic suppression of  claudin-5, so we could not 
follow them up at later time points.
Figure 3. Bmal1 regulates claudin-5 levels at the iBRB. (A) Claudin-5 expression at 8 am and 8 pm in Bmal1fl/fl Tie2-Cre+ mice at 8 am compared to 8 pm 
(n = 5 mice for both time points, P = ns). (B) Claudin-5 transcript levels in WT Cre+, Bmal1WT/fl Tie2-Cre+, and Bmal1fl/fl Tie2-Cre+ mice (n = 7–13 mice per 
group). (C) Claudin-5 expression in retinas of Bmal1fl/fl Tie2-Cre+ at 8 am (left) compared with 8 pm (right), higher magnification. Original magnification, 
×40. (D) FFA in Bmal1fl/fl Tie2-Cre+ at 8 am (top) compared to 8 pm (bottom) showed (E) no significant differences (n = 12 mice for 8 am, and n = 11 mice for 
8 pm). (F) Claudin-5 expression in endothelial cells exposed to serum shock (50% serum) for 2 hours. (G) Suppression efficacy of Bmal-1 siRNA on Bmal-1 
transcript expression (*P = 0.0026, and n = 3). (H) Claudin-5 expression in bEnd.3 cells with suppressed Bmal1 before serum shock exposure. (I) Transendo-
thelial electrical resistance (TEER) measurement in bEnd.3 cells with Bmal1 suppressed (*P = 0.0339, and n = 5). (J) Claudin-5 staining in bEnd.3 cells after 
suppression of Bmal1. Red, claudin-5; green, nuclei. Scale bar: 50 μm. Arrows indicate discontinuity of claudin-5 staining. Student’s t test, with signifi-
cance represented by a P value of less than or equal to 0.05. For multiple comparisons, ANOVA was used with Bonferroni’s post hoc test and significance 
represented by a P value of less than or equal to 0.05.
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The human and nonhuman primate macula is more permeable in the evening, and suppression of  claudin-5 in 
the macula can induce RPE atrophy. To identify the regional expression of  claudin-5 in the human eye, we 
examined CLDN5 transcript expression in the central retina (which includes the macula but also the para-
fovea; the punch from which the RNA was isolated was about 5 mm in diameter) and the midperipheral 
retina (n = 28 donor eyes). Claudin-5 levels were significantly increased in the central macula compared 
with the midperipheral retina (P < 0.0001) (Figure 5A). To determine the integrity of  the iBRB in human 
subjects in the morning compared with the evening, we recruited 15 healthy participants (aged between 18 
and 30 years old) to undergo FFA analysis at a defined time in the morning and again in the evening with 
Figure 4. Persistent claudin-5 suppression induces RPE cell atrophy. (A) FFA in mice injected with an NT shRNA AAV2/9 and fed a normal diet (ND) (top left), 
or HCD (bottom left). FFA analysis of mice injected subretinally with a Cldn5-targeting shRNA AAV2/9 and fed an ND (top right) or an HCD (bottom right) (n = 
12 mice per group). (B) Retinal histology of mouse injected subretinally with an NT shRNA AAV2/9 and fed an HCD (left) or claudin-5–targeting shRNA AAV2/9 
and fed an HCD (right). Blue, DAPI; red, autofluorescence. (C) Semithin sections of mice injected with NT AAV or claudin-5 AAV and fed an HCD. (D) ZO-1 (green) 
staining in flat mounts of mice receiving AAV2/9.NTshRNA subretinally (left) or AAV2/9.CL5shRNA (right). (Images representative of n = 12 mice per group.) (E) 
Schematic representation of retinal interstitial kinesis. Normal paracellular flux of blood-derived components toward the RPE (left). Aberrant flux of material 
from the inner retina inducing RPE atrophy. (F) FFA analysis in Cldn5 Tie2-Cre− mice (left). FFA analysis in Cldn5 Tie2-Cre+ mice (right). Quantitative analysis of 
fluorescein leakage in Cldn5 Tie2-Cre+ mice (***P < 0.001, n = 7 mice for Cldn5 Tie2-Cre−, and n = 8 mice for Cldn5 Tie-Cre+). (G) Claudin-5 (red) expression in Cldn5 
Tie2-Cre− mice (left) compared with Cldn5.Tie2-Cre+ mice (right). Green, IB4. (H) Retinal histology in Cldn5 Tie2-Cre− mice fed an HCD (left) compared with Cldn5 
Tie2-Cre+ mice fed an HCD (right). (n = 7 mice.) Blue, DAPI. Student’s t test was used, with significance represented by a P value of less than 0.05. ANOVA was 
used with Bonferroni’s post hoc test and significance represented by a P value of less than or equal to 0.05. Original magnification, ×40 (B–D, G, and H).
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a minimum of  60 hours between visits. The chronotype of  each person was determined using the Munich 
Chronotype Questionnaire (Supplemental Table 1). For analysis, the macula was divided into 3 regions 
based on the Early Treatment Diabetic Retinopathy Study (ETDRS) grid, comprising (a) central fovea, 
(b) inner macula, and (c) outer macula (Figure 5B). Fluorescein signal was evident and more prolonged 
in the evening compared with the morning in the same subject (Figure 5, C and D), and this was signifi-
cantly increased in all macular regions analyzed (n = 15 subjects, and P < 0.001). The phenotype was also 
observed in nonhuman primates, whereby increased fluorescein signal was observed in the macula in the 
evening compared with the morning (n = 6 monkeys, 12 eyes) (Figure 5, E–G, P < 0.05).
Although the use of  mouse models of  disease has added greatly to our understanding of  human con-
ditions, it must be recognized that mice lack a cone-rich macula similar to the human retina. Therefore, we 
designed an AAV expressing a doxycycline-inducible shRNA targeting a homologous region of  the human 
and African green monkey claudin-5 mRNA. Three monkeys were injected subretinally superiorly in the 
macular region with an AAV targeting claudin-5 or inferiorally with an NT AAV. Monkeys were supple-
mented with doxycycline in their diet for 3 weeks after injection, and FFA analysis showed clear fluorescein 
extravasation at the site of  claudin-5 AAV injection (superior macula) compared with the NT AAV (inferior 
macula) (Figure 5H). Optical coherence tomography (OCT) analysis of  the region of  injection showed 
normal laminar structure in NT AAV–injected regions (Figure 5I); however, aberrant RPE structure was 
clearly evident at the claudin-5 AAV–injected site (Figure 5J). This phenotype was confirmed by histologi-
cal analysis of  retinal cryosections of  this region (Figure 5K).
Discussion
Here, we describe for the first time to our knowledge an inner retina–derived contribution to RPE cell atro-
phy. Our series of  observations could have major implications for the prevention of  AMD in general and 
more specifically of  GA secondary to dry AMD.
Figure 5. Regulation of the iBRB in humans and nonhuman primates. (A) Claudin-5 expression in the central human retina compared with the peripheral 
retina (n = 28 donor human eyes, and ***P < 0.0001). (B) ETDRS grid over the human macula. (C) FFA in the human retina 30 seconds, 5 minutes, and 10 
minutes after i.v. sodium fluorescein injection (top, morning; bottom, evening). (D) Significantly increased fluorescein signal in evening compared with 
morning in the central fovea (CFT) (**P < 0.01), inner macula (***P < 0.001), CFT and inner macula (***P < 0.001), outer macula (***P < 0.001), and total 
area combined (***P < 0.001). (E) FFA analysis from the nonhuman primate (top, morning; bottom, evening). (F) Individual fluorescence signal in each 
monkey at morning compared with evening at 2 minutes (*P = 0.0109) and (G) 6 minutes (*P = 0.0113) after i.v. injection (n = 6 monkeys, 12 eyes). (H) FFA 
analysis of retina injected subretinally with claudin-5–targeting shRNA AAV in the superior macula and NT AAV in the inferior retina and FFA analysis per-
formed in the morning (left) and evening (right). (n = 3 monkeys.) (I) OCT analysis of the NT AAV–injected and (J) claudin-5 shRNA AAV–injected region. (K) 
Histological analysis of retina injected with AAV2/9 expressing claudin-5–targeting shRNA (n = 3 monkeys, 6 eyes). Original magnification, ×40. Student’s t 
test, with significance represented by a P value of less than or equal to 0.05.
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We have shown that the major iBRB-associated tight junction component, claudin-5, cycles in a 
distinct circadian rhythm and is regulated by the circadian clock component BMAL1. Claudin-5 is one 
of  the central mediators of  paracellular passive diffusion of  material from blood to retina and vice versa 
and appears to be a critical factor in allowing for the daily passive diffusion of  dietary material from the 
blood to the retina (13, 14). In this regard, we have shown that size-selective passive diffusion of  system-
ically injected tracer molecules will move from the inner retinal vasculature into the retinal parenchyma 
and diffuse toward the outer retina and RPE in mice, nonhuman primates, and human subjects. This is 
important because an inner retina–derived contributor to RPE pathology has not been described previ-
ously to our knowledge and may represent a critically important and early physiological process central 
to the development of  AMD.
We have shown that chemical and genetic ablation of  Bmal-1 function can prevent claudin-5 cycling and 
affect the integrity of  endothelial cells when RNAi-mediated suppression of  Bmal-1 transcripts is induced. 
RNAi-based experiments highlighted the importance of  Bmal-1 turnover in regulating claudin-5 expression 
because knockout of  Bmal1 from endothelial cells prevented its cycling in vivo but decreased the levels of  
claudin-5 overall in RNAi-based experiments. It is of  note that BMAL1-mediated circadian rhythmicity is 
dysregulated in the aged population (25–27), and it is tempting to suggest aberrant claudin-5 cycling in the 
human retina with age is a contributing factor to drusen accumulation and subsequent RPE atrophy.
It is well known that poor diet and smoking are major risk factors for AMD (28). Here, we found that a 
cholesterol-enriched diet in tandem with low levels of  claudin-5 expression were enough to rapidly produce 
a pathological RPE, suggesting that individuals with suppressed cycling of  claudin-5 may exacerbate RPE 
pathology with poor dietary intake.
For the treatment of  CNV secondary to wet AMD and GA secondary to dry AMD, retinal translo-
cation surgical procedures were previously undertaken in an effort to restore visual acuity in patients by 
surgically translocating the healthy neural retina from the atrophic RPE–affected area to a region of  intact 
RPE cells. Although these techniques represented advanced and technically demanding surgeries, they 
proved successful for a subgroup of  patients with subfoveal CNV. It was of  note, however, that up to 47% of  
patients exhibited RPE atrophy in the translocated region within 45 months of  surgery, suggesting an inner 
retina–derived process that could promote RPE cell stress and death (29, 30). Interestingly, iBRB break-
down has been related to a rare juvenile retinal condition, Coats’ disease, where leakage of  blood-derived 
cholesterol crystals and lipid-laden macrophages infiltrate and fill the subretinal space. The pathophysiol-
ogy of  this condition lends weight to an inner retinal vascular-derived deposition of  material toward the 
RPE (31). It must also be noted that endothelial cells become hyperpermeable in conditions such as diabet-
ic retinopathy, independent of  any overt RPE atrophy. We postulate, however, that chronic and size-selec-
tive disruption of  the iBRB will lead to the accumulation of  material in the RPE over a prolonged period. 
We therefore propose a circadian-entrained cycling of  the permeability of  the inner retinal vasculature as 
a key contributing factor to a dynamic retinal interstitial kinesis that allows for replenishment of  substrate 
to the photoreceptors and the clearance of  material from the neural retina daily. We propose that in the 
aging eye, with dysregulation of  the circadian clock, this interstitial process ceases to be tightly regulated 
and therefore will overload the RPE with spent metabolites and dietary components that will lead to dru-
sen deposition and eventual RPE atrophy. Although our data presented cannot yet speak to the cycling of  
claudin-5 at the iBRB in the aging eye, ongoing studies aimed at elucidating changes in retinal permeability 
in preclinical species and AMD patients will extend our observations.
Overall, our findings directly implicate claudin-5 as a key mediator of  subsequent RPE pathology and 
suggest that methods aimed at restoring the dynamic expression of  this molecule in the aging eye may pre-
vent or indeed halt the progression of  AMD.
Methods
Animal experiments and experimental groups. All studies carried out in the Smurfit Institute of  Genetics in 
Trinity College Dublin (TCD) adhered to the principles laid out by the internal ethics committee at TCD, 
and all relevant national licenses were obtained before commencement of  all studies. C57BL/6J mice were 
sourced from Jackson Laboratory and bred on-site at the Smurfit Institute of  Genetics in TCD. Before 
experiments, all mice were kept on a 12-hour light/12-hour dark cycle with lights on at 8 am and lights off  
at 8 pm. For experiments involving inversed cycles, mice were kept on a 12-hour light/12-hour dark cycle 
with lights on at 8 pm and lights off  at 8 am for a minimum of  3 weeks.
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Hematoxylin and eosin staining. Paraffin sections were deparaffinized by dipping 10 times in xylene 
followed by rehydration in 10 dips each of  100%, 90%, and 70% ethanol. Slides were incubated in hema-
toxylin solution for 6 minutes, rinsed in water, and then incubated in eosin solution for 2 minutes. Slides 
were rinsed in water and dehydrated by dipping 10 times in 70%, 90%, and 100% ethanol and once in 
xylene. Coverslips were placed on slides using Sub-X Mounting Medium (Leica Biosystems). Slides were 
analyzed under a light microscope (Olympus 1X81).
Indirect immunostaining of  retinal flat mounts and retinal cryosections. Mouse retinal cryosections (12-μm thick) 
were fixed with methanol for 10 minutes at –20°C, washed twice in PBS, and blocked/permeabilized with 5% 
normal goat serum (NGS) and 0.5% Triton X-100 in 1× PBS for 30 minutes at room temperature. Sections 
were incubated with primary antibodies (rabbit anti–mouse claudin-5, Invitrogen, 34-1600, and rabbit anti–
mouse ZO-1, Invitrogen, 40-2200) at 4°C overnight. Sections were washed 3 times for 5 minutes each in PBS 
and incubated with fluorescent-labeled secondary antibodies (goat anti–rabbit Cy3, Abcam, ab6939, and goat 
anti–rabbit Cy2, Abcam, ab150077) (1:500) for 2 hours at room temperature followed by three 5-minute wash-
es with PBS. To label blood vessels, sections were costained with Isolectin-IB4 Alexa Fluor 488 (Invitrogen, 
I21411) (1:300). All sections were counterstained with Hoechst 33258 (MilliporeSigma, B2261) (1:10,000) for 
30 seconds and mounted with Aqua Poly/Mount (Polysciences, Inc). Images were acquired using a Zeiss LSM 
710 confocal laser scanning microscope. Identical acquisition settings were used to acquire images, and image 
processing was performed in Adobe Photoshop and ImageJ (NIH).
Western blot analysis. Retinal tissue and cells were lysed in RIPA lysis buffer with phosphatase and pro-
tease inhibitors (MilliporeSigma), incubated on ice for 10 minutes, and centrifuged at 12,000 g at 4°C for 
20 minutes. Ten micrograms of  protein was resolved on 12% SDS polyacrylamide gels. Proteins were trans-
ferred to PVDF membranes and blocked for 1 hour at room temperature in 5% nonfat milk and Tris-buff-
ered saline containing 0.1% Tween-20 solution (TBST). Membranes were then incubated with primary 
antibodies against claudin-5 (1:1000, Invitrogen, 34-1600), Bmal-1 (1:1000, Bethyl Laboratories Inc., A302-
616A), and β-actin (1:5000, Abcam, ab8227) overnight at 4°C; washed twice for 5 minutes each in TBST; 
and incubated with HRP-conjugated goat anti–rabbit secondary antibody (1:5000, MilliporeSigma, A6154) 
for 2 hours at room temperature. After four 10-minute washes in TBST, protein bands were visualized using 
enhanced chemiluminescence (Advansta) with an image analyzer (LI-COR C-DiGit scanner). Densitom-
etry was performed using ImageJ with protein bands of  interest normalized to the loading control β-actin.
qPCR analysis. Reverse transcription PCR (RT-PCR) was carried out using a SensiFAST SYBR 
Hi-ROX Kit (Bioline) according to the manufacturer’s instructions. PCR was performed in a Step-One 
Plus Real-Time PCR instrument (Applied Biosystems). RT-PCR conditions were as follows: 95°C for 10 
minutes, 37 cycles of  95°C for 15 seconds, and 60°C for 30 seconds. A melt curve stage was added: 95°C 
for 15 seconds, 60°C for 1 minute, and 95°C for 15 seconds. The comparative ΔΔCT method was used 
to quantify changes in mRNA levels between treatment groups. The following primers were designed 
using Primer3: claudin-5 forward, 5′-TTTCTTCTATGCGCAGTTGG-3′; reverse, 5′-GCAGTTTGGT-
GCCTACTTCA-3′; occludin forward, 5′-ACAGTCCAATGGCCTACTCC-3′; reverse, 5′-ACTTCAG-
GCACCAGAGGTGT-3′; ZO-1 forward, 5′-CCACCTCTGTCCAGCTCTTC-3′; reverse, 5′-CAC-
CGGAGTGATGGTTTTCT-3′; Bmal-1 forward, 5′-ATCAGCGACTTCATGTCTCC-3′; reverse, 
5′-CTCCCTTGCATTCTTGATCC-3′; and β-actin forward, 5′-TCACCCACACTGTGCCCATCTAC-
GA-3′; reverse, 5′-CAGCGGAACCGCTCATTGCCAATGG-3′
Biotin permeability assay. Mice were injected i.v. through the tail vein with 2 mg/mL EZ-Link 
Sulfo-NHS-Biotin (600 Da). Eyes were enucleated 5 minutes after biotin injection and immersion fixed in 
4% paraformaldehyde (PFA, pH 7.4) overnight at 4°C. Eyes were cryoprotected by sequential incubations in 
10%, 20%, and 30% sucrose and frozen in OCT freezing medium (VWR). Mouse retinal cryosections were 
incubated with Cy3-conjugated streptavidin (1:200) overnight at 4°C to label Sulfo-NHS-Biotin. Biotin leak-
age was visualized with a Zeiss LSM 710 confocal laser scanning microscope. Image analysis was performed 
in ImageJ by drawing regions of  interest outside blood vessels and measuring the mean pixel intensity.
MRI. iBRB integrity was assessed in vivo via MRI, using a dedicated small-rodent 7-T MRI system 
located at TCD (https://www.tcd.ie/Neuroscience/technologies/neuroimaging.php). Anesthetized 
mice were physiologically monitored (ECG, respiration, and temperature) and placed on an MRI-com-
patible support cradle, with a built-in system for maintaining the animal’s body temperature at 37°C. 
The cradle was then positioned within the MRI scanner. Accurate positioning was ensured by acquir-
ing an initial rapid pilot image, which was then used to ensure the correct geometry was scanned in 
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all subsequent MRI experiments. T1-weighted magnetic resonance images (resolution, 0.156 × 0.156 
× 5 mm3; field of  view: 20 × 20 × 17.9 mm3; matrix: 128 × 128 × 30; TR/TE: 500/2.7 ms; flip angle: 
30°; number of  averages: 3; acquisition time: 2 minutes, 24 seconds; repetitions: 12) were acquired 
following administration of  100 μL of  a 1:3 dilution of  gadolinium diethylene–triamine penta-acetic 
acid (Gd-DTPA), administered via the tail vein. A quantitative assessment of  iBRB integrity was also 
made using DCE-MRI, in which the passage of  Gd-DTPA from the vasculature into the tissue was 
monitored over a period of  10 minutes after injection.
AAV2/9 design and generation. shRNAs designed to target transcripts derived from mouse or Afri-
can green monkey claudin-5 were incorporated into AAV-2/9 vectors.  Claudin-5 shRNA was sub-
cloned into the pSingle-tTS-shRNA (Clontech) vector, which uses a doxycycline-inducible promoter. 
The plasmid incorporating the inducible system with claudin-5 shRNA was digested with BsrBi and 
BsrGI and ligated into the Not1 site of  the plasmid pAAV-MCS so as to incorporate left and right AAV 
inverted terminal repeats. AAV-2/9 was then generated using a triple transfection system in a stably 
transfected HEK293 cell line for the generation of  high-titer viruses (Vector BioLabs).
Cldn5-knockdown mouse generation. Mice were generated by standard blastocyst injection (32) at 
Charles Rivers Laboratory in collaboration with Mirimus Inc using their strict VAF/Elite health stan-
dards. A doxycycline-inducible claudin-5 shRNA was knocked in at the Col1a1 locus on chromo-
some 11. Additionally, a CAG-lox-stop-lox-rtTA3-IRESmKate2 (CLR3K) allele was knocked in at 
the Rosa26 locus on chromosome 6. Mice homozygous for the claudin-5 shRNA–containing gene and 
the reverse tetracycline-controlled transactivator gene were crossed to Tie2-Cre–expressing animals 
for endothelial-specific expression of  claudin-5 shRNA. Cre-negative littermate mice were used as 
controls. Doxycycline was administered to the drinking water (2 mg/mL in 2% sucrose solution) to 
activate shRNA expression and replenished 3 times a week.
FFA and OCT analysis. FFA and OCT were performed on mice using a Heidelberg SPECTRALIS OCT 
(Heidelberg Engineering). Pupils were dilated with 1% tropicamide and 2.5% phenylephrine and mice anesthe-
tized using a mixture of ketamine and domitor. Mice were intraperitoneally injected with sodium fluorescein (2 
mg/mL) at the same volume/weight (100 μL/20 g) to visualize the blood vessels. For the size selectivity study, 
mice were injected with the same volume/weight of FITC-Dextran FD4 (MilliporeSigma, 2 mg/mL) in a sim-
ilar fashion to sodium fluorescein. FFA images were captured from 2 minutes to 10 minutes every 30 seconds. 
FFA and OCT images were captured with a 30° angle of view. Heidelberg Eye Explorer (HEYEX) version 
1.7.1.0 was used to capture images. For quantification of microvessel permeability, ImageJ was used for analysis.
RNAi experiment. Brain endothelial cells (bEnd.3) (ATCC) were transfected with 10 pmol NT or Bmal-
1 siRNA using Lipofectamine 2000 transfection reagent (Thermo Fisher Scientific) diluted in OptiMEM 
reduced serum medium (Thermo Fisher Scientific) according to the manufacturer’s instructions. For-
ty-eight hours after transfection, medium was replaced with medium containing 50% fetal calf  serum, and 
cells were serum shocked for 2 hours. Following serum shock, cells were incubated in serum-free medium, 
and protein lysates were collected every 4 hours for 28 hours.
Immunocytochemistry. Confluent bEnd.3 cells were washed twice in PBS and fixed with 4% PFA for 10 
minutes at room temperature. Following fixation, cells were washed twice with PBS and blocked/permea-
bilized with 5% NGS and 0.05% Triton X-100 in PBS for 1 hour at room temperature. Cells were incubated 
in primary antibody against claudin-5 (Invitrogen, 34-1600) (1:100) overnight at 4°C. Cells were washed 
3 times with PBS and incubated with goat anti–rabbit Cy3 (Abcam, ab6939) (1:500) secondary antibody 
for 2 hours at room temperature, followed by 4 washes with PBS. Nuclei were stained with Hoechst 33258 
(1:10,000). The slide was removed from the chamber and mounted with Aqua Poly/Mount (Polysciences, 
Inc) before visualization by confocal laser scanning microscopy.
TEER. TEER measurements were performed on cells grown on 6.5-mm-diameter, 0.4-μm-pore, 
polyester membrane HTS Transwell inserts (Corning Costar). TEER values were measured using an 
EVOM resistance meter (MilliporeSigma) fitted with “chopstick” electrodes. Before measurements, 
the apical and basolateral chambers were replaced with fresh medium. TEER values were recorded 
in triplicate, and the average value of  a no-cell compartment was subtracted from the average of  the 
triplicate measurements. TEER values were expressed as ohm × cm2 (Ω × cm2).
High-fat diet and HCD study. C57BL/6J mice were fed ad libitum an HCD (Envigo, TD.88051).
Nonhuman primate study. Six monkeys were used for the FFA study, while 3 monkeys were used for the 
subretinal AAV study. Pupils were dilated with 1% tropicamide and 2.5% phenylephrine hydrochloride drops. 
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Subretinal injections of  AAV expressing claudin-5 shRNA under the control of  a doxycycline-inducible pro-
moter were performed under a surgical microscope in 3 African green monkeys under aseptic conditions 
under ketamine/xylazine anesthesia (5.0 mg/kg ketamine [Fort Dodge]/1.0 mg/kg xylazine [Lloyd Lab] 
administered intramuscularly in a sterilely mixed cocktail to effect). After placement of  a lid speculum, a radi-
al conjunctival peritomy incision was made in the superior temporal quadrant and a pars plana sclerotomy 
site marked on the sclera. A sclerotomy incision was made at the marked location using a 25-gauge MVR 
knife. After an anterior chamber paracentesis by 30-gauge needle at the limbal cornea, and application of  a 
sterile hydroxypropyl methylcellulose contact lens coupling solution, a Machemer fundus contact lens was 
placed on the cornea. A 30-gauge anterior chamber cannula, used as a subretinal injector, was then intro-
duced through the superior temporal sclerotomy into the vitreous cavity under the operating microscope. The 
cannula was then maneuvered so that it was apposed to the posterior temporal retinal surface at an oblique 
angle. The cannula was advanced to catch a fold of  retina on the cannula tip and then advanced further 
to pierce the retina, avoiding injury to the underlying RPE and choroid. AAV was then injected in a small 
volume to confirm position and patency of  the cannula tip. Once subretinal positioning was confirmed, the 
total target volume of  100 μL of CLDN5 AAV-2/9 or AAV9shAnti-Luc control vector was injected, with 
monitoring of  the injection under direct visualization through the microscope. The cannula was then removed 
from the retina and scleral insertion site. Tobramycin and dexamethasone ointment (Tobradex, Alcon) was 
administered topically following the injection procedure.
Nonhuman primate FFA. Fundus color photography and FFA were performed on 6 ketamine/xylazine–
anesthetized animals using a retinal camera (Topcon TRC 50X, Topcon America Corp) with Canon D4 
digital imaging hardware and New Vision Fundus Image Analysis System software. FFA in the left eye 
was preceded by angiography in the right eye by 6 hours to allow adequate time for washout of  fluorescein 
between image series. Color and red-free images were collected from each eye before infusion of  0.1 mL/kg 
10% sodium fluorescein into the saphenous vein. A rapid series of  angiogram images were collected from 
the posterior pole immediately after completion of  the infusion for the first minute and then at 2, 3, and 
6 minutes. A single angiogram was also taken from the contralateral eye after collection of  the 6-minute 
angiogram image to ensure intereye consistency in fluorescein levels in the optic nerve head and normal 
vasculature. Color and red-free photographs and fluorescein angiograms were collected from each animal 
at 14 days after injection.
Nonhuman primate OCT examinations. OCT was performed using a Heidelberg Spectralis OCT Plus with 
eye tracking and HEYEX image capture and analysis software. Images were acquired from all the eyes at 
baseline, immediately after injection, and at 14 days (immediately before sacrifice). At all time points an 
overall volume scan of  the entire macula was performed at a dense scan interval, encompassing the subret-
inal injection site where applicable.
Nonhuman primate termination. On day 42 after injection, monkeys were euthanized by pentobarbital 
overdose while under ketamine sedation and globes were enucleated. Globes were marked at the 12’00 
position with indelible ink before enucleation. Extraocular tissues were trimmed and the globes were placed 
into 4% PFA fixative without further manipulation. Following 24-hour fixation the globes were maintained 
in PBS with 0.05% sodium azide until sectioning for histopathology and immunohistochemistry.
Human FFA study. Fifteen healthy volunteers were recruited from Dublin, Ireland, and informed 
consent was obtained from all participants. Fundus color photography was performed using a retinal 
camera (Topcon TRC 50X, Topcon America Corp) with Canon D4 digital imaging hardware, and 
FFA was performed using a Heidelberg Spectralis OCT (Heidelberg Engineering). Pupils were dilat-
ed with 1% tropicamide and 2.5% phenylephrine. Sodium fluorescein (500 μg), followed by a 5-mL 
flush of  0.9% sodium chloride, was injected via a peripheral cannulation site, to visualize the blood 
vessels of  the posterior pole. Color and red-free images were collected from each eye before injection 
of  sodium fluorescein. FFA images of  the posterior pole were captured every 15 seconds from com-
pletion of  the infusion to 10 minutes. The images were captured with a 30° angle of  view in the left 
eye of  all participants. HEYEX version 1.7.1.0 was used to capture images. Fundus images were inde-
pendently reviewed by a consultant ophthalmologist, and ImageJ analysis was used for quantification 
of  microvessel permeability.
Human donor eye RNA analysis. Peripheral nasal retina and central retina, including the macula, were 
isolated from human donor eyes within an average of  approximately 11 hours and frozen separately (n = 28 
donor eyes). RNA was isolated using the RNeasy kit (Qiagen).
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Circadian open-source data. Initial data outlining claudin-5 transcript cycling outlined in Figure 1, A 
and B, were collated from open-source data available on http://cirgrdb.biols.ac.cn/ and referenced in 
Xianfeng et al. (33).
Statistics. Statistical analysis was performed using a 2-tailed Student’s t test, with significance represent-
ed by a P value of  less than or equal to 0.05 when 2 individual experimental groups were being analyzed. 
For multiple comparisons, 1-way ANOVA was used with Bonferroni’s post hoc test and significance repre-
sented by a P value of  less than or equal to 0.05. Error bars represent SEM.
Study approval. All ethical approvals for animal and human experiments outlined in this study were 
obtained from relevant local and national competent authorities before the initiation of  the studies. Studies 
outlined in animals and humans were reviewed and approved by an appropriate institutional review board. 
The TCD Animal Research Ethics Committee approved all animal mouse studies. The St Kitts Biomedical 
Research Foundation approved all nonhuman primate studies. The Royal Victoria Eye and Ear Hospital 
Research Foundation ethics committee approved the human studies. Informed consent was obtained from 
each participant in the human FFA study.
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